One to Watch: Aerovate TherapeuticsNASDAQ:AVTE to gap fill?? Possibly going back to $32 from ... @2 one to keep on the watchlist
Biotech alert! Aerovate Therapeutics is working on a treatment for rare lung diseases, specifically pulmonary arterial hypertension. Founded in 2018, this MA-based company is one to watch! #biotech #AerovateTherapeutics
AVTE trade ideas
Aerovate Therapeutics not delivering. AVTEThis one is particularly disappointing due to more than just the chart. The company has not delivered on its promises. It is a common sight in pharma/biotech startups.
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe!